Certified by Founder Lodge
Laverock Therapeutics
United Kingdom - Stevenage, England
START UP
1 Disclosed Funding Rounds $16,470,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Next generation programmable cell therapies
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 28 ,2023 | Seed | $16,470,000 |
Eli Lilly and Company
Mercia Asset Management PLC
Maven Capital Partners
Eos
UK Innovation & Science Seed Fund
Tekfen Ventures
Calculus Capital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Govstream.ai | $3,600,000 | (Dec 5, 2025)
ZincFive, Inc. | $30,000,000 | (Dec 5, 2025)
imper.ai | $28,000,000 | (Dec 5, 2025)
SPhotonix Inc | $4,500,000 | (Dec 5, 2025)
Multifactor (YC F25) | $15,000,000 | (Dec 5, 2025)
